|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Consolidated net income | |||||
| Loss from discontinued operations, net of tax | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Loss (gain) on extinguishment of debt | |||||
| Loss on sale of property, plant, and equipment | |||||
| Loss on goodwill impairment | |||||
| Loss on intangible asset impairment | |||||
| Gain on insurance recovery of inventory loss | |||||
| Loss (gain) from equity method investments | |||||
| (Gain) Loss on investments | |||||
| Depreciation and other amortization expense | |||||
| Amortization of other intangible assets | |||||
| Amortization of deferred financing costs | |||||
| Deferred income tax expense | |||||
| Stock compensation expense | |||||
| Gain on MSA escrow deposits | |||||
| Noncash lease income | |||||
| Gain on MSA investments | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Other current assets | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued liabilities and other | |||||
| Operating cash flows from continuing operations | |||||
| Operating cash flows from discontinued operations | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Capital expenditures | |||||
| Acquisitions, net of cash acquired | |||||
| Purchases of investments | |||||
| Proceeds from sale of investments | |||||
| Purchase of options agreement | |||||
| Purchases of non-marketable equity investments | |||||
| Proceeds on sale of property, plant and equipment | |||||
| MSA escrow deposits, net | |||||
| Investing cash flows from continuing operations | |||||
| Investing cash flows from discontinued operations | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from Senior Notes | |||||
| Payments of 2018 first lien term loan | |||||
| Total payments of 2018 first lien term loan | |||||
| Settlement of interest rate swaps | |||||
| Convertible Senior Notes repurchased | |||||
| Payment of 2026 Senior Notes | |||||
| Proceeds from 2032 Notes | |||||
| At the market offering proceeds | |||||
| Interchange subscription agreement | |||||
| Proceeds from call options | |||||
| Payment of promissory note | |||||
| Payment of dividends | |||||
| Payments of financing costs | |||||
| Exercise of options | |||||
| Redemption of options | |||||
| Redemption of restricted stock units | |||||
| Issuance of restricted stock units | |||||
| Redemption of performance based restricted stock units | |||||
| Issuance of performance based restricted stock units | |||||
| Common stock repurchased | |||||
| Financing cash flows from continuing operations | |||||
| Financing cash flows from discontinued operations | |||||
| Net cash provided by (used in) financing activities | |||||
| Net increase (decrease) in cash | |||||
| Unrestricted | |||||
| Restricted | |||||
| Total cash at beginning of period | |||||
| Total cash at end of period | |||||
| Effect of foreign currency translation on cash | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash paid during the period for interest | |||||
| Cash paid during the period for income taxes, net | |||||
| Accrued capital expenditures | |||||
| Accrued consideration for acquisition of investments | |||||
| Dividends declared not paid | |||||
Loading...